Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Coronary Aspiration Thrombectomy: not always, not ever
Session:
Posters (Sessão 6 - Écran 6) - Síndromes Coronárias Agudas e Crónicas
Speaker:
António Maria Rocha de Almeida
Congress:
CPC 2023
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
12. Coronary Artery Disease (Chronic)
Subtheme:
12.8 Coronary Artery Disease - Other
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
António Maria Rocha De Almeida; Miguel Carias; David Neves; Francisco Claudio; Marta Paralta Figueiredo; Kisa Congo; Manuel Trinca; Lino Patrício
Abstract
<p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><strong>Background</strong></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif">Traditionally, routine thrombus aspiration during primary percutaneous coronary intervention (PCI) was performed to prevent distal embolization and protect microvascular perfusion. However, recent trials showed no clinical benefits (except if high thrombotic burden). Despite not being routinely recommended, thrombus aspiration should still be considered in highly thrombotic circumstances. </span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><strong>Material and methods</strong></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif">Prospective cohort of 50 patients admitted to primary PCI, with aspiration thrombectomy (AT), between 2019–2022, was analyzed. In evidence of high thrombotic burden, AT was performed, if technically possible. Success was evaluated angiographically and by TIMI flow improvement. Safety was assessed by neurologic evaluation, verified CT-scan, in 30 days follow-up. </span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif"><strong>Results and conclusions</strong></span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif">50 patients were analyzed, with mean age of 59,6±1,8 years, being 22% women (n=11). 88% (n= 44) presented ST-segment elevation myocardial infarction Killip 1, 2% (n=1) Killip 3 and 10% (n=5) Killip 4. There was angiographic evidence of thrombus aspiration in 76% (n=38) and TIMI flow increase in 82% (n= 41) cases with median improvement of 2 [IR 1,3]. In 20% (n=10) cases, stent wasn’t implanted. There was significant statistical association between no stent PCI and angiographical thrombus reduction (P<0,05, OR 3,86). There were no deaths, major adverse cardiovascular events (MACE), or neurologic complications in any patient (n=0) within 30 days. Routine coronary AT shouldn’t be performed. It is useful, however, in selected cases with evidence of angiographic thrombus aspiration and TIMI flow improvement. Successful AT was associated with no stent PCI. Regarding safety, there was no statistically significant increase of death of any cause, MACE, or stroke>< 0,05, OR 3,86). There were no deaths, major adverse cardiovascular events (MACE), or neurologic complications in any patient (n=0) within 30 days.</span></span></p> <p style="text-align:justify"><span style="font-size:12pt"><span style="font-family:Calibri,sans-serif">Routine coronary AT shouldn’t be performed. It is useful, however, in selected cases with evidence of angiographic thrombus aspiration and TIMI flow improvement. Successful AT was associated with no stent PCI. Regarding safety, there was no statistically significant increase of death of any cause, MACE, or stroke.</span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site